A comparative study between Etomidate and Thiopentone was carried out on 100 healthy female patients scheduled for post-partum abdominal sterilization under epidural analgesia.
Our results show Etomidate to be a safe and effective induction agent, comparable to Thiopentone in having a rapid onset of action and rapid recovery time. The pulse rates and blood pressures remained relatively stable during the use of Etomidate. However, there was a high incidence of transient respiratory upsets while causing less respiratory depression than Thiopentone. The objectionable features of Etomidate are high incidence of pain on injection and involuntary muscular activity, which account for the low anaesthetist acceptance rate.
References
1.
AtkinsH. (1966): “Conduct of a controlled trial”. Brit. Med. J., 2, 377.
2.
DoenickeA., KuglerJ., PenzelG., LaubM., KalmarL., KillianI., and BezecnyH. (1973): “Brain function and safety after iv use of etomidate, a new barbiturate-free hypnotic”, Anaesthetist.22, 357.
3.
DoenickeA., LorenzW., BeighR., BezecnyH., UhligG., KalinarL., PraetoriusB., and MannG. (1973): “Histamine release after intravenous application of short-acting hypnotics”. Brit. J. Anaesth., 45, 1097.
4.
DoenickeA., GabanyiD., LemcheH., and Schurk-Bulichim (1974): “Circulatory dynamics and myocardial function following three short-acting intravenous hypnotics: etomidate, propanidid and methohexital”, Anaesthetist, 23, 108.
5.
GhoneimM. M., and YamadaT. (1977): “Etomidate: a clinical and electroencephalographic comparison with thiopental”. Anesth. Analg., 56, 479.
6.
GoodingJ. M., and CorssenG. (1976): “Etomidate: an ultrashort acting nonbarbiturate agent for anaesthesia induction”, Anesth. Analg., 55, 286.
7.
HoldcroftA., MorganJ.G., WhitwamJ. G., and LumleyJ. (1976): “Effect of dose and premedication on induction complications with etomidate”, Brit. J. Anaesth., 48, 199.
8.
JanssenP. A. J., NiemegeersC. J. E., SchellekensK. H. L., and LenaertsF. M. (1971): “Etomidate (R - (+) - 1 - (methylbenzyl) imidazole-5-carboxylate (R 16659) — a potent short-acting and relatively atoxic intravenous hypnotic agent in rats”. Arzneim Forsch.21, 1234.
9.
Janssen Pharmaceutica (1976): Clinical research report.
10.
KayB. (1976): “A clinical assessment of the use of etomidate in children”. Brit. J. Anaesth., 48, 207.
11.
KettlerD., SonntagH., DonathU., RegensburgerD., and SchenkH. D. (1974): “Hemodynamics. myocardial mechanics, oxygen requirements and oxygen consumption of the human heart during etomidate induction into anaesthesia”. Anaesthetist, 23, 116.
12.
MorganM., LumleyJ., and WhitwamJ. G. (1975): “Etomidate, a new water-soluble non-barbiturate intravenous induction agent”, Lancet, 1, 955.
13.
MorganM., LumleyJ., and WhitwamJ. G. (1977): “Respiratory effects of etomidate”, Brit. J. Anaesth., 49, 233.
14.
WeymarA., EigenheerF., GethmannJ. W., ReineckeA., PatschkeD., TarnowJ., and BrucknerJ. B. (1974): “Experimental animal studies on the effects of etomidate (R26 490 Sulphate) on the circulation and myocardial oxygen supply”, Anaesthetist, 23, 150.
